DACRIN strategy and research focus

​The DACRIN strategic plan 2024 – 2029 builds on the successes of past and current collaborative research activities. We will continue to grow and strengthen our network through a strategic approach to research, communication, and partnerships.

Our vision

Expanded and enhanced evidence-informed practice that improves the safety, efficiency, clinical outcomes and client experiences of alcohol and other drug (AOD) services.

Our mission

To facilitate the conduct of quality AOD clinical research and improvement activities by enhancing collaboration between clinicians, consumers and researchers.

Our strategic priorities and goals

Priority 1: Lead drug and alcohol clinical research

Our agenda is collaborative, diverse, rigorous, and driven by clinical needs and consumer priorities.      

  • Peer review and endorsement of research proposals to ensure scientific rigour and relevance
  • Set the research agenda through formal processes that reflect NSW AOD priorities
  • Better use of data to guide clinical research, quality improvement, and pilot studies

Priority 2: Build clinical research and translation capacity 

Our network has the capacity to produce practice-changing outcomes.

  • Training and professional development for emerging and existing researchers
  • Research infrastructure to support collaborative development and ensure quality by design
  • Translation activities to scale up and share findings using technology and targeted dissemination

Priority 3: Expand the network and influence change

Our inclusive network is recognised for its contributions to AOD clinical research.

  • Grow network membership across disciplines, jurisdictions, and regions
  • Promote communication and brand awareness to build stakeholder confidence
  • Strategic influence to address barriers and improve translation into practice

Our research priorities

 DACRIN’s research priorities guide our endorsement decisions and collaborative initiatives. Developed through consultation with Council members and affiliates, they reflect the sector’s collective voice and aim to improve AOD care across NSW.

  1. Drive Evidence-Informed Interventions
    Develop, evaluate, and implement effective treatments, programs, and services.
  2. Embed Consumer and Peer-Led Research
    Ensure lived and living experience informs research questions, methods, and outcomes.
  3. Harness Data to Drive Insights and Improvements
    Use linked clinical and administrative data to identify gaps and opportunities.
  4. Improve Access and Outcomes in Underserved Populations
    Focus on Aboriginal communities, rural and remote residents, young people, and those with co-occurring conditions.
  5. Respond to Emerging Issues and Evidence Gaps
    Address evolving challenges, including emerging substances and changing patterns of use.
  6. Strengthen the AOD Workforce and System Integration
    Build capacity and foster collaboration with a focus on trauma-informed, gender-sensitive, and culturally safe care.

Our commitment

Through our Strategic Plan DACRIN is committed to:

  • Ensuring quality by design in our research and quality assurance activities
  • Fostering and supporting consumer involvement 
  • Building and strengthening our network to advance AOD clinical research throughout NSW

Our achievements

Explore our recent progress through the annual reports below. Each report contains summaries of milestones, achievements and successes.

DACRIN annual progress report 2024

DACRIN achievements 2022-2023

DACRIN achievements 2019-2021​ ​

Current as at: Tuesday 21 October 2025